RETINOL bINDING PROTEIN AS A MARKER OF CARDIOVASCULAR RISK IN ARTERIAL HYPERTENSION AND ObESITY
https://doi.org/10.15829/1560-4071-2018-4-14-18
Abstract
Aim. To assess the influence of retinol-binding protein synthetized by adipose tissue, on clinical course and prognosis of arterial hypertension (AH).
Material and methods. Totally, 168 patients included, with AH of 1-3 grade. Study protocol included general clinical investigation (at inclusion, in 1, 4 and 9 months) with analysis of complaints, anamnesis, physical examination, additional laboratory and instrumental methods. In 78 patients among the included, the level of retinolbinding protein RBP4 was measured in blood serum.
Results. Increased level of RBP4 correlated significantly with the age, body mass index, duration of AH, raised level of uric acid, pulse wave velocity signs, endogenic nitrite. Only in the group with raised RBP4 there was stroke anamnesis noted, and obesity of III grade. Dynamics of the level of RBP4 during 9 months treatment, depending on cardiometabolic risk, showed some specifics: at inclusion, in the group with high cardiometabolic risk there was significantly increased RBP4 comparing to the groups of patients with low and moderate cardiometabolic risk.
Conclusion. Increased level of retinol-binding protein is associated with higher cardiometabolic risk and adverse prognosis.
About the Authors
Yu. A. Vasyuk
A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD).
Moscow.
Moscow.
I. A. Sadulaeva
A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD).
Russian Federation
Moscow.
Russian Federation
Moscow.
E. N. Yushchuk
A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD).
Moscow.
Moscow.
O. S. Trofimenko
A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD).
Moscow.
Moscow.
S. V. Ivanova
A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD).
Moscow.
Moscow.
References
1. Jungheim ES, Travieso JL, Carson KR, Moley KH. Obesity and reproductive function. Obstetrics and gynecology clinics of North America. 2012; 39 (4): 479-93. DOI: 10.1016/j. ogc.2012.09.002.
2. Jiao L, Berrington de Gonzalez A, Hartge P, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control. 2010; 21 (8): 1305-14. DOI: 10.1007/s10552-010-9558-x. Epub 2010 Apr 10. 3.
3. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care. 2007; 10 (2): 142-8. DOI: 10.1097/MCO.0b013e328042ba90.
4. Balarini C, Braga V. New Translational Insights on Metabolic Syndrome: Obesity, Hypertension, Diabetes and Beyond. Front. Phisiol. 2016; 10; 7: 229. DOI: 10.3389/ fphys.2016.00229. eCollection 2016.
5. Se Eun Park, Nam Seok Lee, Ji Woo Park, et al. Association of urinary RBP4 with insulin. European Journal of Endocrinology. 2014; 171: 443-9. DOI: 10.1530/EJE-14-0247.
6. Moraes-Vieira PM, Yore MM, Dwyer PM, et al. RBP4 Activates Antigen-Presenting Cells, Leading to Adipose Tissue Inflammation and Systemic Insulin Resistance. Cell Metabolism. 2014; 19: 512-26. DOI: 10.1016/j.cmet.2014.01.018.
7. Sadulaeva IA, Vasyuk YuA, Trofimenko OS, et al. Obesity in metabolic syndrome and renal dysfunction. Ter. archive. 2016; 88, 10: 93-8. (In Russ.) Садулаева И. А., Васюк Ю. А., Трофименко О. С. и др. Ожирение при метаболическом синдроме и почечная дисфункция. Тер. архив 2016; 88, 10: 93-8. DOI: 10.17116/terarkh201688693-98.
8. Shlyakhto EV, Nedogoda SV, Konradi AO, et al. THE CONCEPT OF NOVEL NATIONAL CLINICAL GUIDELINES ON OBESITY. Russian Journal of Cardiology. 2016; (4): 7-13. (In Russ.) . Шляхто Е. В., Недогода С. В., Конради А. О., и др. КОНЦЕПЦИЯ НОВЫХ НАЦИОНАЛЬНЫХ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ОЖИРЕНИЮ. Российский кардиологический журнал. 2016; (4): 7-13. DOI: 10.15829/1560-4071-2016-4-7-13.
9. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006, Jun 15; 354 (24): 2552-63. DOI: 10.1056/NEJMoa054862.
10. Gao S, Li M, Wang Z, et al. Serum levels of retinol-binding protein-4 and its association with metabolic syndrome in first-degree relatives of type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi. 2009 Aug 11; 89 (30): 2129-33. DOI: 10.3760/cma.j.issn.0376-2491.2009.30.013.
11. Nikolaos PE, Kadoglou NP, Lambadiari V, et al. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability. Atherosclerosis. 2014; 5, 606-12. DOI: 10.1016/j.atherosclerosis.2014.05.957.
Review
For citations:
Vasyuk Yu.A., Sadulaeva I.A., Yushchuk E.N., Trofimenko O.S., Ivanova S.V. RETINOL bINDING PROTEIN AS A MARKER OF CARDIOVASCULAR RISK IN ARTERIAL HYPERTENSION AND ObESITY. Russian Journal of Cardiology. 2018;(4):14-18. (In Russ.) https://doi.org/10.15829/1560-4071-2018-4-14-18
Views:
2089
Email this article 